150 related articles for article (PubMed ID: 28485366)
1. Plasma cell leukemia: Single institution experience.
Babu KG; Jacob LA; Agarwal A; Lakshmaiah KC; Lokanatha D; Suresh Babu MC; Rajeev LK; Lokesh KN; Rudresha AH
Indian J Cancer; 2016; 53(4):619-620. PubMed ID: 28485366
[TBL] [Abstract][Full Text] [Related]
2. Plasma cell leukemia: a report on 15 patients.
Bernasconi C; Castelli G; Pagnucco G; Brusamolino E
Eur J Haematol Suppl; 1989; 51():76-83. PubMed ID: 2697596
[TBL] [Abstract][Full Text] [Related]
3. Plasma cell leukemia. A report on 11 patients and review of the literature.
Pasqualetti P; Festuccia V; Collacciani A; Acitelli P; Casale R
Panminerva Med; 1996 Sep; 38(3):179-84. PubMed ID: 9009684
[TBL] [Abstract][Full Text] [Related]
4. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
Alghasham N; Alnounou R; Alzahrani H; Alsharif F
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell leukemia: a rare condition.
Jiménez-Zepeda VH; Domínguez VJ
Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Plasma Cell Leukemia in the Czech Republic.
Zapletalova M; Krejci D; Jarkovský J; Muzik J; Dusek L; Pour L
Klin Onkol; 2019; 32(1):47-51. PubMed ID: 30764629
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China.
Peijing Q; Yan X; Yafei W; Dehui Z; Zengjun L; Junyuan Q; Yaozhong Z; Lugui Q
Acta Haematol; 2009; 121(1):47-51. PubMed ID: 19339770
[TBL] [Abstract][Full Text] [Related]
8. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia.
Cha CH; Park CJ; Huh JR; Chi HS; Suh CW; Kang YK
Acta Haematol; 2007; 118(3):178-82. PubMed ID: 17934254
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of patients with plasma cell leukemia in the era of novel therapies and hematopoietic stem cell transplantation strategies: a single-institution experience.
Lebovic D; Zhang L; Alsina M; Nishihori T; Shain KH; Sullivan D; Ochoa-Bayona JL; Kharfan-Dabaja MA; Baz R
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):507-11. PubMed ID: 21813352
[TBL] [Abstract][Full Text] [Related]
10. Plasma cell leukemia--a study of 28 cases from India.
Majumdar N; Kumar R; Anand M; Kalita D; Ghara N; Chopra A; Medhi K; Sharma A; Kumar L; Raina V
Hematology; 2009 Aug; 14(4):198-203. PubMed ID: 19635182
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of bortezomib in patients with plasma cell leukemia.
Musto P; Rossini F; Gay F; Pitini V; Guglielmelli T; D'Arena G; Ferrara F; Filardi N; Guariglia R; Palumbo A; ; ;
Cancer; 2007 Jun; 109(11):2285-90. PubMed ID: 17469169
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell leukemia.
Albarracin F; Fonseca R
Blood Rev; 2011 May; 25(3):107-12. PubMed ID: 21295388
[TBL] [Abstract][Full Text] [Related]
13. Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register.
Nahi H; Genell A; Wålinder G; Uttervall K; Juliusson G; Karin F; Hansson M; Svensson R; Linder O; Carlson K; Björkstrand B; Kristinsson SY; Mellqvist UH; Blimark C; Turesson I
Eur J Haematol; 2017 Sep; 99(3):216-222. PubMed ID: 28544116
[TBL] [Abstract][Full Text] [Related]
14. Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.
Katodritou E; Terpos E; Kelaidi C; Kotsopoulou M; Delimpasi S; Kyrtsonis MC; Symeonidis A; Giannakoulas N; Stefanoudaki A; Christoulas D; Chatziaggelidou C; Gastari V; Spyridis N; Verrou E; Konstantinidou P; Zervas K; Dimopoulos MA
Am J Hematol; 2014 Feb; 89(2):145-50. PubMed ID: 24123068
[TBL] [Abstract][Full Text] [Related]
15. Plasma Cell Leukemia – the Forgotten Disease.
Žárska M; Vrábel D; Bezdekova R; Štork M; Jarošová M; Adam Z; Krejčí M; Pour L; Ševčíková S
Klin Onkol; 2019; 32(1):40-46. PubMed ID: 30764628
[TBL] [Abstract][Full Text] [Related]
16. [Primary plasma cell leukemia. Report of five cases].
Mendoza MG; Valladares X; Roa M; Reyes M; Osorio R; Undurraga MS; Legües ME; Cabrera ME; Peña C
Rev Med Chil; 2019; 147(1):18-23. PubMed ID: 30848760
[TBL] [Abstract][Full Text] [Related]
17. Primary plasma cell leukemia occuring in the young.
Raj RS; Najeeb S; Aruna R; Pavithran K; Thomas M
Indian J Cancer; 2003; 40(3):116-7. PubMed ID: 14716116
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
Wang H; Zhou H; Zhang Z; Geng C; Chen W
Turk J Haematol; 2020 May; 37(2):91-97. PubMed ID: 31769277
[TBL] [Abstract][Full Text] [Related]
19. Thirty patients with primary plasma cell leukemia: a single center experience.
Colović M; Janković G; Suvajdzić N; Milić N; Dordević V; Janković S
Med Oncol; 2008; 25(2):154-60. PubMed ID: 18488157
[TBL] [Abstract][Full Text] [Related]
20. Primary plasma cell leukemia: a Surveillance, Epidemiology, and End Results database analysis between 1973 and 2004.
Ramsingh G; Mehan P; Luo J; Vij R; Morgensztern D
Cancer; 2009 Dec; 115(24):5734-9. PubMed ID: 19877113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]